Understanding Midd Training Module 1
Let's dive into the details surrounding Midd Training Module 1. This lecture by Jeffrey Barrett from the Critical Path Institute describes the
Key Takeaways about Midd Training Module 1
- Stacy Tannenbaum, lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, reviews the various ...
- This lecture by Drs. Adekemi, Taylor, Rajesh Krishna and S.Y. Amy Cheung, Senior Directors of Integrated Drug Development at ...
- Dr. Jeff Barrett from the Critical path Institute describes the application of
- Stacy Tannenbaum, the lead of the Pharmacometrics Group in the US for Astellas Pharma Global Development, discusses ...
- Do you have questions for the workshop speakers? Please email: MIDDWorkshop@fda.hhs.gov Detailed agenda: ...
Detailed Analysis of Midd Training Module 1
Jeffrey Barrett from the Critical Path Institute provides the overview of this Rajesh Krishna, Senior Director with IDD Certara, reflects on how decision analysis can be used to support drug development. Dr. Qi Liu, the Assoc. Director for Innovation & Partnership in the Office of Clinical Pharmacology, Office of Translational Sciences ...
This lecture by Dr. Rajesh Krishna is a case study showing how anti-viral kinetic modeling can be used to support drug ...
That wraps up our extensive overview of Midd Training Module 1.